Related Experiment Video
Updated: Jul 20, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Clinical aspects of parvovirus B19 infection
K Broliden1, T Tolfvenstam, O Norbeck
1Department of Medicine, Solna, Unit of Infectious Diseases, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden. kristina.broliden@karolinska.se
Abstract:
Parvovirus B19 is a significant human pathogen that causes a wide spectrum of clinical complications ranging from mild, self-limiting erythema infectiosum in immunocompetent children to lethal cytopenias in immunocompromised patients and intrauterine foetal death in primary infected pregnant women. The infection may also be persistent and can mimic or trigger autoimmune inflammatory disorders. Another important clinical aspect to consider is the risk of infection through B19-contaminated blood products. Recent advances in diagnosis and pathogenesis, new insights in the cellular immune response and newly discovered genotypes of human parvoviruses form a platform for the development of modern therapeutic and prophylactic alternatives.
More Related Videos
Related Concept Videos
Cytomegalovirus Disease
Poliomyelitis
Respiratory Syncytial Virus Disease
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Viral Meningitis
Myocarditis II: Clinical Features and Diagnostic Tests

